ChengDa Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jul '25 Jul 15, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	4,815	3,057	3,934	4,912	-	-	Upgrade
Market Cap Growth	-2.53%	-22.31%	-19.91%	-	-	-	Upgrade
Enterprise Value	3,815	1,875	2,523	3,463	-	-	Upgrade
Last Close Price	31.79	20.00	24.93	30.90	-	-	Upgrade
PE Ratio	-	-	43.24	46.13	-	-	Upgrade
PS Ratio	15.61	9.18	9.50	11.94	-	-	Upgrade
PB Ratio	2.25	1.43	1.73	2.22	-	-	Upgrade
P/TBV Ratio	2.29	1.45	1.75	2.25	-	-	Upgrade
P/OCF Ratio	-	106.70	20.48	103.06	-	-	Upgrade
EV/Sales Ratio	12.37	5.63	6.09	8.42	-	-	Upgrade
EV/EBITDA Ratio	-	-	25.67	32.80	-	-	Upgrade
EV/EBIT Ratio	-	-	43.75	49.28	-	-	Upgrade
Debt / Equity Ratio	0.04	0.04	-	-	0.13	0.02	Upgrade
Debt / EBITDA Ratio	-	-	-	-	0.48	0.08	Upgrade
Debt / FCF Ratio	-	-	-	-	-	0.15	Upgrade
Asset Turnover	0.13	0.14	0.17	0.27	0.68	0.69	Upgrade
Inventory Turnover	1.54	1.56	1.67	1.75	2.66	3.11	Upgrade
Quick Ratio	7.98	5.97	8.69	14.99	0.76	1.59	Upgrade
Current Ratio	9.20	6.84	9.58	16.88	1.53	2.49	Upgrade
Return on Equity (ROE)	-2.17%	-1.25%	4.05%	7.75%	20.28%	29.31%	Upgrade
Return on Assets (ROA)	-2.34%	-1.79%	1.51%	2.92%	11.51%	11.79%	Upgrade
Return on Capital (ROIC)	-2.50%	-1.94%	1.60%	3.12%	13.12%	13.45%	Upgrade
Return on Capital Employed (ROCE)	-	-	2.50%	3.20%	20.90%	21.90%	Upgrade
Earnings Yield	-1.00%	-0.92%	2.31%	2.17%	-	-	Upgrade
FCF Yield	-6.18%	-8.43%	-0.83%	-3.22%	-	-	Upgrade
Dividend Yield	0.68%	1.00%	0.80%	0.61%	-	-	Upgrade
Payout Ratio	-	-	31.89%	41.12%	31.20%	18.85%	Upgrade
Buyback Yield / Dilution	1.76%	1.75%	-2.12%	-30.56%	0.00%	-9.67%	Upgrade
Total Shareholder Return	2.52%	2.75%	-1.32%	-29.96%	0.00%	-9.67%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.